Slower flow rate, which means a slightly slower injection
Most patients see meaningful results within the first 416 weeks
in fact, the GIP component may even help with nausea for some
This dual-agonism activity of tirzepatide may contribute to the greater weight reduction observed with tirzepatide than with semaglutide, a mono agonist used in the current trial. Safety data Adults in both groups had improvements in systolic blood pressure, diastolic BP, HbA1c, fasting glucose and lipid levels
These medications affect multiple systems in the body, including hydration levels, blood sugar regulation, and digestion, all of which can contribute to the onset of headaches
The 7.5 mg/mL concentration (2.0 mL water) creates an interesting option